Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,179
Closed -$4.63M 805
2025
Q2
$4.63M Buy
13,179
+230
+2% +$75.3K 0.04% 339
2025
Q1
$4.1M Sell
12,949
-82
-0.6% -$27.5K 0.04% 360
2024
Q4
$4.4M Buy
13,031
+170
+1% +$57K 0.04% 352
2024
Q3
$4.1M Sell
12,861
-49,829
-79% -$15.8M 0.04% 400
2024
Q2
$20.2M Buy
62,690
+13,293
+27% +$4.36M 0.2% 98
2024
Q1
$17.1M Buy
49,397
+35,888
+266% +$12.1M 0.17% 114
2023
Q4
$4.9M Buy
13,509
+14
+0.1% +$4.15K 0.05% 328
2023
Q3
$4.02M Sell
13,495
-54
-0.4% -$17.1K 0.04% 350
2023
Q2
$4.47M Sell
13,549
-127
-0.9% -$40.2K 0.05% 341
2023
Q1
$4.55M Sell
13,676
-11
-0.1% -$3.1K 0.05% 337
2022
Q4
$3.31M Buy
13,687
+51
+0.4% +$11.9K 0.04% 408
2022
Q3
$3.02M Sell
13,636
-17
-0.1% -$4.34K 0.04% 417
2022
Q2
$3.27M Buy
+13,653
New +$3.61M 0.04% 390

Other funds holding ANSS

New York Life Investment Management's ANSS Position: Q3 2025 in Review

New York Life Investment Management sold out of Ansys (ANSS) in Q3 2025, closing a stake of 13,179 shares — an estimated $4.63M sold.

New York Life Investment Management first reported a position in ANSS in Q2 2022 and held it in 13 quarters. The position peaked at $20.2M in Q2 2024. 7 funds tracked by Wall St. Rank hold ANSS as of Q3 2025.

  • New York Life Investment Management reported no remaining Ansys position as of Q3 2025 after selling out during the quarter.
  • New York Life Investment Management sold 13,179 Ansys shares in Q3 2025, an estimated $4.63M.
  • New York Life Investment Management first reported a position in Ansys in Q2 2022 and held it in 13 quarters.
  • New York Life Investment Management's Ansys position peaked at $20.2M in Q2 2024.
  • 7 funds tracked by Wall St. Rank held Ansys as of Q3 2025.

Based on New York Life Investment Management's 13F filing for Q3 2025, filed 6 Nov 2025.